Emergency Use Authorization for Flowflex Plus COVID-19 & Flu A/B Combo Test
The Acon Laboratories Flowflex Plus COVID-19 and Flu A/B Home Test has received Emergency Use Authorization (EUA) from the FDA.
Category: News
FDA Approves First-Ever OTC Fentanyl Test for Consumer Use
The FDA has approved the first OTC fentanyl test, making it more accessible. This test empowers consumers to detect fentanyl, enhancing safety and awareness.
Game-Changer: FDA Grants Clearance for First COVID-19 Home Antigen Test
At-Home Screening Advancement: FDA Gives Green Light to COVID-19 Antigen Test. The FDA 510(k) Flowflex will be manufactured domestically.
FDA Approval of New Buprenorphine Treatment Option Empowers Recovery Efforts
FDA’s approval of an innovative buprenorphine treatment offers a powerful tool to bolster and empower addiction recovery efforts.
FDA Approves Second Over-the-Counter Naloxone Nasal Spray
Empowering the Public: FDA Approves Another Lifesaving Tool Against Opioid Overdoses.
FDA Approves First RSV Vaccine
FDA’s approval of the first RSV vaccine heralds a new era in public health. DTKUSA, a testing solutions provider, steps forward with crucial testing support.
DrugTestKitUSA Announces Limited-Time Sale on COVID-19 Antigen Test Kits This Winter
COVID-19 did not go anywhere, and testing is now as crucial as ever.
